Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis via Androgen Receptor Signaling-Reference-Cited by-同舟云学术

Ornithine Decarboxylase Is Sufficient for Prostate Tumorigenesis via Androgen Receptor Signaling

Published:2016-12 Issue:12 Volume:186 Page:3131-3145
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Shukla-Dave Amita,Castillo-Martin Mireia,Chen Ming,Lobo Jose,Gladoun Nataliya,Collazo-Lorduy Ana,Khan Faisal M.,Ponomarev Vladimir,Yi Zhengzi,Zhang Weijia,Pandolfi Pier P.,Hricak Hedvig,Cordon-Cardo Carlos

Funder

Margaret Dorrance Strawbridge Foundation

NIH/National Cancer Institute

NIH

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference61 articles.

1. Ornithine decarboxylase activity is critical for cell transformation;Auvinen;Nature,1992

2. Polyamines and prostatic carcinoma: clinical and therapeutic implications;Cipolla;Eur Urol,1993

3. Polyamines and cancer: old molecules, new understanding;Gerner;Nat Rev Cancer,2004

4. Polyamines and cancer: implications for chemotherapy and chemoprevention;Nowotarski;Expert Rev Mol Med,2013

5. Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues;Goodwin;Prostate,2008

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ame‐miR‐1‐3p of bee venom reduced cell viability through the AZIN1/OAZ1‐ODC1‐polyamines pathway and enhanced the defense ability of honeybee (Apis mellifera L.);Insect Molecular Biology;2024-05-20

2. Preventing Cancer by Inhibiting Ornithine Decarboxylase: A Comparative Perspective on Synthetic vs. Natural Drugs;Chemistry & Biodiversity;2024-03-11

3. POLYAMINES IN PROSTATE CANCER: THE RELATIONSHIP WITH THE AGGRESSIVENESS OF TUMORS AND THE RISK OF DISEASE PROGRESSION;Oncology;2023

4. THE INFLUENCE OF SPERMINE AND AMINOGUANIDINE ON THE MORPHOFUNCTIONAL CHARACTERISTICS OF HUMAN PROSTATE CANCER CELL LINE LNCaP;Oncology;2023

5. The testosterone paradox of advanced prostate cancer: mechanistic insights and clinical implications;Nature Reviews Urology;2022-12-21